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STUDY QUESTION:What are healthcare professionals’ barriers and strategies for improvement in female oncofertility care?
SUMMARYANSWER: Professionals perceived barriers in knowledge, attitude and organization of oncofertility care and suggested strategies
to improve oncofertility care.
WHAT IS KNOWN ALREADY: The potential loss of fertility is one of the most important undesirable side effects of cancer treatment
in women of reproductive age. Unfortunately, despite guideline recommendations, not all patients are informed about their fertility risks
and referred for fertility preservation (FP) counselling. Insight into barriers for discussing FP and appropriate referral is necessary before
improvements can be made.
STUDY DESIGN, SIZE, DURATION: The aim of this was study was to identify barriers and gather improvement suggestions through
semi-structured in-depth interviews conducted with 24 professionals working in oncofertility care. Subsequently, an expert panel meeting was
held to reach consensus on a set of improvement strategies.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Oncological professionals were recruited from the three Dutch expertise
hospitals for female FP and their affiliated hospitals. The expert panel consisted of six healthcare professionals, five survivors and two
researchers. In the Dutch setting, financial aspects do not play a role in oncofertility care.
MAIN RESULTS AND THE ROLE OF CHANCE: Barriers were identified and categorized into the patient level (e.g. focus on surviving
cancer), the professional level (e.g. lack of awareness, knowledge, time, and attitude), or the organizational level (e.g. unavailable written
information, disagreement on who is responsible for discussing infertility risks). The expert panel reached consensus on essential elements for
a multifaceted improvement programme: development of information materials (leaflets, online decision aid), education of professionals, a
role for specialized oncology nurses in informing patients and patient navigators at the fertility department to facilitate referral and counselling,
medical record reminders, standard consultations with a gynaecologist and agreement on responsibility.
LIMITATIONS, REASONS FOR CAUTION: Selection bias could have occurred because it is likely that only professionals with interest in
oncofertility care participated. However, this would mean that the barriers were underestimated.
WIDER IMPLICATIONS OF THE FINDINGS: This study forms the basis for the development of a multifaceted oncofertility programme,
which is essential to increase adherence to the national clinical guideline.
STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the Radboud university medical center. The authors have
declared no competing interests. Prof. Dr Braat reports unrestricted grants from Ferring BV, Serono and Goodlife, outside the submitted work.
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Introduction
Over the past decades, the rates of cancer survivorship in young female
patients have increased (De Angelis et al. 2014). Therefore, attention
should be paid to the late side effects of cancer treatment and long-
term quality of life issues (DCOG 2010). One of the most important
undesirable side effects of cancer treatment in women of reproductive
age is the potential loss of fertility. Some women even report the
potential loss of fertility almost as distressing as the battle with cancer
itself (Tschudin and Bitzer 2009). When damage to reproductive
organs is likely, oophoropexy or cryopreservation of embryos or
oocytes are effective options available for women to preserve fertility
prior to starting their cancer treatment; cryopreservation of ovarian
tissue is still considered as experimental (Donnez and Dolmans 2017).
The optimal oncofertility care for young female cancer patients is
described in several evidence-based national and international clinical
practice guidelines (ASRM 2013a; NICE 2013; NVOG 2016; Oktay
et al. 2018). These guidelines recommend discussing the potential loss
of fertility with all female cancer patients and, if desired, offering a
referral to and counselling by a fertility specialist. Hereafter, a patient
can decide whether she wants to undergo fertility preservation (FP)
treatment. Information about fertility issues related to cancer treat-
ment should be provided, irrespective of a female cancer patient’s
reproductive age, parity, and disease type or severity (Oktay et al.
2018). Providing information, referral, and counselling to these patients
affects quality of life positively, reduces long-term regret, and reduces
concerns regarding fertility (Benedict et al. 2016; Deshpande et al.
2015; Letourneau et al. 2012; Oktay et al. 2018).
Unfortunately, studies have shown that despite these evidence-
based recommendations, the rates of patients who received informa-
tion about their fertility risks and FP options still vary greatly, from
51% to 95% (Adams et al. 2013; Forman et al. 2010; Letourneau et al.
2012; Louwe et al. 2018; Niemasik et al. 2012). The referral process
to a fertility specialist also shows variation in practice, with 9.8–67%
of these patients being referred (Adams et al. 2013; Bastings et al.
2014; Quinn et al. 2009). It is important to get insight into barriers for
delivering optimal oncofertility care to reduce this variation in practice
and improve oncofertility care and guideline adherence.
Reported barriers in international literature impeding oncologists
from discussing infertility risks and FP options are as follows: a lack of
time, knowledge, or resources; a need for immediate cancer therapy;
perceived poor success rates of FP options; poor patient prognosis;
and patient characteristics (e.g. higher age and parity) (Adams et al.
2013; Besharati et al. 2016; Jones et al. 2017; Peddie et al. 2012; Quinn
et al. 2007; Quinn et al. 2009). However, most of these studies have
been performed in countries where financial aspects also play a key
role in professionals’ decisions to inform and refer a patient for FP
counselling (Adams et al. 2013; Goodman et al. 2012; Rashedi et al.
2018). In the Netherlands, cancer care and FP options are reimbursed
by standard health care insurance. The first aim of our study was
therefore to assess barriers and improvement suggestions among
healthcare professionals in female oncofertility care in a setting where
financial aspects do not play a role. Furthermore, whereas multiple
studies have assessed barriers in providing optimal oncofertility care,
none have included tailoring improvement strategies. Therefore, the
second aim of our study was to identify essential elements for a tailored
programme to overcome barriers and improve oncofertility care.
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Materials and Methods
Design
Our study consisted of two parts. First, semi-structured in-depth
interviews were conducted with healthcare professionals to identify
their barriers and improvement suggestions in female oncofertility care.
Second, tailored improvement strategies were selected with patient
and healthcare professional experts to overcome the barriers, fitting
it into a nationwide oncofertility programme.
Setting
In the Netherlands, cancer patients receive multidisciplinary oncolog-
ical care and can be referred for specialized FP care by any medical
specialist involved. Dutch breast cancer patients also need referral
to a gynaecologist for FP counselling, because they are operated
on by surgical oncologists. At three Dutch hospitals, all FP options,
including ovarian tissue cryopreservation, are performed (expertise
hospitals: Radboudumc Nijmegen, LUMC Leiden, and Erasmus MC
Rotterdam).
All legal residents of the Netherlands are obliged by law to have
basic health insurance, which covers FP counselling and all FP options,
meaning that patients have no financial reasons to refrain from it.
Study population
Part I: Identification of barriers and improvement suggestions
Professionals involved in Dutch female oncofertility care were eligible
to participate in the study. They included medical, gynaecological
and surgical oncologists, haematologists, specialized oncology nurses,
and reproductive gynaecologists. They were recruited from the three
Dutch expertise hospitals for female FP care (Radboudumc, LUMC,
and ErasmusMC) and their approximately 20 affiliated hospitals. Pro-
fessionals (N=43) were approached by the researcher (MB) by email
to participate. Depending on the professional’s preference, interviews
were conducted in person or via telephone. They were not offered
compensation for their participation.
Part II: Selection of improvement strategies
Both patients and professionals were eligible to participate in the expert
panel meeting. Patients were recruited from the following patients’
networks: Olijf (gynaecological cancers), AYA (national adolescent and
young adult) platform, and the patient advisory board of the research
theme Women’s Cancers at the Radboudumc. Professionals were
recruited from the Radboudumc and its affiliated hospitals. In total, 22
experts were invited to participate.
Data collection and analysis
Part I: Identification of barriers and improvement suggestions
Semi-structured, in-depth interviews were performed to identify pro-
fessionals’ barriers and improvement suggestions. Interviews were
preferred over a survey because we wanted to obtain in-depth and
detailed information on barriers and improvement suggestions.
The interview guide was based on key recommendations for high-
quality female oncofertility care, previously identified by our research
team (ÖB, MB, DB, WN, RH, CB). These key recommendations were
extracted and selected by a multidisciplinary expert panel from six
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national and international guidelines, then appraised as high-quality
guidelines by our research team, complemented with the Dutch guide-
line using a Delphi consensus procedure (Baysal et al. 2018). The
key recommendations are distributed over the FP healthcare pathway
for patients (risk communication, referral, counselling, and decision-
making) and shown in Supplementary Table I. Barriers and improve-
ment suggestions regarding risk communication and referral were
discussed in the interviews, while barriers regarding counselling and
decision-making have been identified previously (Bastings et al. 2014).
Different levels, based on the framework developed by Flottorp
et al. 2013, were used to explore barriers and improvement sug-
gestions. This framework facilitates identification and assessment of
potential barriers using seven levels: guideline-related factors, patients,
professionals, professional interactions, incentives and resources, orga-
nization, and social, legal and political characteristics. The interview
guide was adapted when new barriers or improvement suggestions
were identified, and is provided in the Supplementary Information.
All interviews were conducted by M.B. in 2016, and the number of
interviews was determined by data saturation (the point at which no
new information was mentioned). To confirm that no new information
was mentioned, three additional interviews were conducted.
In order to analyse data, all interviews were recorded and tran-
scribed verbatim. Transcripts were not returned to participants for
comments. The texts were imported in qualitative research software
Atlas.ti (version 7.1.5,Berlin) and codingwas, again, guided by Flottorp’s
framework (Flottorp et al. 2013). The coding process consisted of four
steps. All steps were performed independently by two researchers (MB
andÖB) to increase reliability and validity. First, all interview transcripts
were read. Second, both researchers selected and labelled phrases in
which potential barriers or improvement suggestions were described
using open encoding. These codes were then grouped into categories
and finally, these categories were assigned to the appropriate levels,
as described by Flottorp. After each step, the results were compared,
and any discrepancies were discussed until consensus was reached.
If no consensus was reached, a third independent person (WN) was
consulted. The inter-coder score was calculated by percent agreement,
because it is unlikely that agreement would occur by chance (Lombard
2002). The two coders agreed on 717 out of the initial 778 codes
(92% agreement) and discussed about 61 out of 778 codes (8%
disagreement). All disagreements included codes that were initially
missed and not coded by either one of the researchers. The inter-coder
score of 92% is deemed acceptable (Lombard 2002).
Part II: Selection of improvement strategies
In the second part of our study, an expert panel meeting was held in
2018 to select improvement strategies to overcome the identified bar-
riers. Again, the framework of Flottorp was used (Flottorp et al. 2013).
To select strategies, a prioritization of barriers was necessary, because
barriers that have a large influence on the performance objective are
likely to be important targets for an intervention.
The expert panel meeting was led by the main researcher (MB)
and started with the presentation of all barriers identified in the inter-
views, complemented with the barriers identified in previous research
(Bastings et al. 2014). All barriers are presented in Table II. Thereafter,
the expert panel was divided into three subgroups, each consisting
of patients and professionals. Each subgroup separately discussed all
barriers, added new barriers, and scored the impact of each barrier
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on a scale of one to three. The impact score represented to what
extent the barrier hindered the adherence to the key recommendation
(1: minor extent, 2: moderate extent, 3: major extent) (Flottorp et al.
2013). Thus, for three subgroups, the minimum score was three and
the maximum score was nine.
The scores of all subgroups were added together for each barrier,
and a priority list was made. The top eight identified barriers were
considered most important because of the feasibility of implementing
adherent improvement strategies for a total of eight barriers in a
multifaceted improvement strategy (Grimshaw et al. 2012; Kersten
et al. 2017). These eight barriers and their associated improvement
strategies were discussed with the entire expert panel as part of
the development of a multifaceted programme, taking into account
the improvement suggestions identified in part I. Finally, the selection
of improvement strategies was based on the suggestions made by
the professionals in the in-depth interviews, on the priority given
by the expert panel and on previous research (Flottorp et al. 2013;
Kok et al. 2016). Thus, both exploratory and theory-inspired methods
were used to select interventions as is recommended in the review by
Wensing et al. 2010.
Ethical approval
Approval for this study by an ethics committee was not required, in line
with Dutch guidelines. The study was performed in accordance with
the Declaration of Helsinki, and written consent was obtained from all
participants.
Results
Part I: Identification of barriers and
improvement suggestions
In total, 24 out of 43 individual professionals agreed to participate
in the interviews. Reasons for declining participation were a lack of
time (N=4), not experiencing problems in FP discussions (N=2),
and not responding to the initial or follow-up invitations (N=13). The
participants’ characteristics are presented in Table I.
A total of 28 barriers and 18 improvement suggestions were iden-
tified in the interviews, categorized into the patient, professional,
and care organization level. Table II shows all barriers and Table III
shows all improvement suggestions. Both are ranked by the number of
times they were mentioned (range, 1–23). Barriers and improvement
suggestions mentioned most by the professionals are described in the
text below. To provide a degree of quantification, we have used words
to define rates of mentions: almost all, most, some, half and a third.
Supplementary Table II shows illustrative quotes of some suggested
barriers.
Patient level
Barriers
Most oncological professionals reported that they feel that patients do
not place fertility high on their priority list because they are focused
on surviving cancer. Furthermore, according to some professionals,
patients are not motivated to preserve their fertility because they want
to start their cancer treatment as soon as possible.
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Table I Participants’ characteristics.
Part of study Characteristics Value,N (%)
.......................................................................................................................................................................................
Part I Type of professional (N=24)
Medical oncologist 7 (29%)
Surgical oncologist 7 (29%)
Gynaecological oncologist 2 (8%)
Haematologist 1 (4%)
Specialized oncology nurse 1 (4%)
Specialized breast cancer nurse 4 (17%)
Reproductive gynaecologist 2 (8%)
Gender
Male 3 (12%)
Female 21 (88%)
Type of hospital
Academic hospital 15 (63%)
Non-academic hospital 9 (37%)
Years of experience
0–5 years 3 (12%)
5–9 years 11 (46%)
10–19 years 5 (21%)
20–29 years 5 (21%)
Number of oncofertility patients professionals treat yearly
≤10 patients 2 (8%)
11–20 patients 10 (42%)
21–30 patients 5 (21%)
>30 patients 6 (25%)
Unknown 1 (4%)
Part II Type of experts (N=13)
Researchers, quality of care 2 (15%)
Professionals 6 (46%)
Medical oncologist 2
Gynaecological oncologist 1
Specialized oncology nurse 1
Specialized fertility nurse 2
Survivors 5 (39%)
Breast cancer 2
Gynaecological cancer 2
Soft tissue sarcoma 1
Gender
Male 1 (8%)
Female 12 (92%)
Part I: Barrier and improvement suggestion identification. Part II: Selection of improvement strategies.
Improvement suggestions
Almost all professionals think an online individualized decision-aid on
oncofertility and handing out information leaflets at the oncology
department will improve oncofertility care. Furthermore, they think
that it would help if patients themselves were aware of infertility
risks when they receive gonadotoxic cancer treatments. Awareness
could be created, for example, by a national campaign by the cancer
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society, or through more online information by disease-specific cancer
associations.
Professional level
Barriers
Most professionals reported that they routinely discuss FP, but lack
the knowledge of the FP options, methods, and tools, particularly
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Table II Professionals’ barriers in female oncofertility care.
Phase of FP Level Barrier
.......................................................................................................................................................................................
Risk
communication
and referral
Patient Fertility is not a priority for patients; they focus on surviving cancer∗
Patients are not motivated; they focus on immediate cancer treatment
Patients are scared of IVF
Patients do not come up with the fertility topic themselves
Professional Professionals lack knowledge
– of FP options∗
– of infertility risks
– regarding FP options in different cancer types
Particularly professionals working in non-academic hospitals lack knowledge of FP
Professionals lack awareness
– of the decision aid∗
– of the FP guideline
– in patients with an older age∗
– in patients with a higher parity
– in patients with a poor prognosis
– in patients without a (active) wish to conceive
– in mentally disabled patients
– in single patients
Particularly surgical oncologists lack awareness of FP
Professionals have a lack of time∗
– professionals have to provide too much information at diagnosis
– professionals do not provide written information
Professionals have a lack of agreement
– surgical oncologists believe that medical oncologists are responsible for FP discussions
– if there is no definitive treatment plan
Professionals have a lack of self-efficacy
– FP is a difficult topic for them to discuss
Professionals have a lack of outcome expectancy
– professionals think they scare women when they discuss FP
Organization Written information is not available∗
FP is not discussed at multidisciplinary meetings
It is difficult to arrange an appointment with a gynaecologist for a patient
Disagreement between departments on who is responsible for fertility discussions
No nurses are available to support professionals
Counselling and Patient Patients do not feel supported
decision-making Patients’ preferences are not taken into account by gynaecologists
Professional Professionals have a lack of communication
– patients do not have the opportunity to ask all questions
Professionals provide incomplete information
– not all applicable options are discussed
– not all benefits and disadvantages of FP options are clearly explained
Organization Written information is not available
Professionals lack time for counselling
FP, fertility preservation; IVF, in vitro fertilization.
∗More than 50% of all professionals mentioned the barrier.
the options corresponding to different cancer types. In addition, most
professionals reported being less aware of discussing fertility in patients
who are of a higher age, who have children, who don’t have a (clear)
wish to conceive or who have a poor cancer prognosis.
Furthermore, half of the professionals reported lacking the time to
discuss fertility, because they have to give a large amount of information
regarding the cancer diagnosis in the first consultation with a new
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patient. Regarding professionals’ attitude towards FP, themost frequent
mentioned barrier was disagreement between surgical oncologists and
medical oncologists on who is responsible for discussing infertility risks.
Improvement suggestions
Improving professionals’ awareness of FP is an important suggestion.
Most professionals think this could be achieved through education by
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Table III Professionals’ improvement suggestions in female oncofertility care.
Phase of FP Level Improvement suggestion
.......................................................................................................................................................................................
Risk communication and
referral
Patient Development and provision of patient information materials
– Decision aid∗
– Leaflets∗
– Option grid
Increase patients’ awareness
Professionals refer women for FPC who have doubts
Professional Education of professionals∗
– Educate professionals’ way of communication
Increase professionals’ awareness∗
Surgical oncologists refer women for FPC∗
Feedback to professionals on their performance
Organization Role for specialized oncology nurses∗
Fertility is a standard item at multidisciplinary meetings∗
Easy referral process∗
Standard consultations with a gynaecologist for all female cancer patients of
reproductive age∗
Reminders in medical record
Agreement between healthcare departments on who is responsible for fertility
discussions
Fertility is mentioned in each cancer-specific protocol
Counselling and
decision-making
Organization Implementation of a patient navigator at the fertility department
FPC, fertility preservation counselling.
∗More than 50% of all professionals mentioned the improvement suggestion.
gynaecologists with expertise in FP. Furthermore, most profession-
als reported that surgeons should refer breast cancer patients to a
gynaecologist for FP counselling in order to leave more time for FP
before cancer treatment. Another suggested improvement is to create
awareness among oncological professionals on positive or negative
ways of communication about infertility risks and FP options.
Organization level
Barriers
At the level of the organization, the barrier most frequently mentioned
was the lack of available written FP information at their department.
Furthermore, at a third of the hospitals, fertility issues are not routinely
discussed at the weekly multidisciplinary team meetings (i.e. meetings
where treatment plans for all newly diagnosed cancer patients are
discussed).
Improvement suggestions
Almost all professionals mentioned that specialized oncology nurses
should have a role in FP care, because nurses have more interest in
the psychosocial aspect of the cancer diagnosis. It may, therefore, be
logical to give them a role in the FP discussion. Furthermore, almost
all professionals reported that fertility should be discussed at those
weekly multidisciplinary teammeetings, including appointing a primarily
responsible physician at each hospital.
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Part II: Selection of improvement strategies
In total, 13 out of 22 experts agreed to participate in the expert panel
meeting. The reason for declining participation was a lack of time.
Participants’ characteristics are shown in Table I.
Patients in the expert panel agreed with the identified barriers among
professionals. Two additional barriers were identified by the patients
in the expert panel: namely, that prior to the cancer treatment only
the medical perspective is discussed at multidisciplinary teammeetings,
without a mention of consequences for fertility and that no attention
is paid to reproductive concerns after cancer treatment. Based on
the scores of all subgroups for each barrier, a priority list was made.
Table IV shows the top eight barriers distributed over the FP healthcare
pathway for patients, and the seven selected improvement strategies
on which consensus was reached to overcome these barriers.
Discussion
This study reports the findings of a qualitative, in-depth assessment of
perceived barriers and improvement suggestions among professionals
working in oncofertility care. Barriers have been revealed by using the
model of Flottorp and have been categorized into patient, professional,
and organizational levels. On the patient level, a focus on surviving
cancer instead of fertility, on the professional level, a lack of awareness
and a lack of knowledge, and on the organizational level, a lack of
available written information and disagreement on who is responsible
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Table IV Barriers and their impact score including the selected improvement strategies.
Phase of FP Impact score Barrier Adherent improvement
strategies
.......................................................................................................................................................................................
Risk communication 9 Lack of knowledge 1
Referral 9 Lack of awareness 1, 2, 3
9 Disagreement between departments on who is responsible for fertility
discussions
4
8 No written information available 5
8 Fertility is not a priority for cancer patients 3, 5, 6
7 Lack of time 6
Counselling 7 Incomplete information in FP counselling 5,7
Decision-making 7 Gynaecologist does not take patients’ preferences into account 7
No attention for reproductive concerns after cancer treatment∗ 6,7
Impact score: three subgroups scored to what extent the barrier hindered the adherence to a recommendation (1: minor extent, 2: moderate extent, 3: major extent). Minimum
score: 3; maximum score: 9.Adherent improvement strategies that overcome barriers:1. Education of professionals 2. Reminders in medical record 3. Standard consultation
with gynaecologist for all female cancer patients of reproductive age 4. Agreement between healthcare departments on who is responsible for fertility discussions 5. Written and online
information materials (leaflets, decision aid) 6. Role for specialized oncology nurses 7. Role for patient navigators at fertility department
∗Barrier newly added by the expert panel
for discussing fertility, were mentioned as main barriers for optimal
oncofertility care. During the expert panel meeting, in which patients
also took part, these barriers were confirmed and the barrier that
no attention is paid to reproductive concerns after cancer treatment
was added. The improvement strategies selected by the expert panel
were as follows: development and availability of patient information
materials (leaflets, decision aid), education of professionals, a role
for specialized oncology nurses in discussing fertility issues, reminders
in the medical record, standard consultations with a gynaecologist,
agreement in each hospital on who is responsible to discuss infertility
risks, and a role for patient navigators at the fertility department.
To the best of our knowledge, this is the first study to identify
barriers and tailor improvement strategies to these barriers to deliver
optimal oncofertility care. Previous studies have examined barriers or
improvements separately, but not concurrently. The identified barriers
were in line with earlier studies, in which a lack of professionals’
knowledge and patients’ characteristics (higher age, higher parity, and
poor cancer prognosis) were also identified as barriers (Adams et al.
2013; Jones et al. 2017; Quinn et al. 2007; Quinn et al. 2009). It is
striking that despite the presence of national clinical guidelines and
a national website on FP (www.nnf-info.nl), the main barriers among
professionals were still a lack of awareness and a lack of knowledge.
A possible explanation is that professionals are unaware of these
guidelines, because they are published in journals and websites that
are mainly read by gynaecologists and not by professionals working
in oncology care. Therefore, in an attempt to overcome this barrier,
the most recent national FP guideline is also published on the Dutch
national oncology website and on the national guideline database
(NVOG 2016).
Another identified barrier was that professionals feel that women
focus on surviving cancer and not on their risk of infertility. Earlier
studies have also identified this, the need for immediate therapy either
by the professional or by the patient (Jones et al. 2017; Niemasik
et al. 2012; Quinn et al. 2007). However, other studies reported
that cancer survivors have more decisional conflict and regret, and a
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lower quality of life if they had not received specialized FP counselling
(Letourneau et al. 2012; Mersereau et al. 2013). An implication of this
finding is that professionals should correctly prioritize the fertility topic
at the appropriate moment. Therefore, education of professionals is
needed, in particular on oncofertility knowledge and communication
skills. Moreover, specialized oncology nurses can play an important role
in this. The effectiveness of nurses participating in oncofertility care
has already been studied; nurses feel responsible for addressing fertility
issues, patients are more satisfied, andmore referrals for FP counselling
take place (Cohen et al. 2016; Krouwel et al. 2017; Srikanthan et al.
2016).
One of the strengths of our study is the recruitment of a great
diversity of professionals from the three Dutch expertise academic
hospitals for female FP care and their affiliated non-academic hospitals.
This provides a reflection of the perceived barriers and improvement
suggestions throughout the Netherlands. Another strength is the in-
depth insight into the barriers and improvement suggestions, in con-
trary to previous studies where only a quantitative assessment was
performed. This provided us with more detailed information and more
input to select improvement strategies.
This study also has some limitations. First, all professionals were
asked for participation via email. It is likely that only professionals with
interest in oncofertility care participated in this study. However, this
would mean that we have underestimated the number of barriers and
that even more barriers exist. To identify non-participants’ barriers,
we could have sent an online survey. However, 13 out of the 19
participants who declined participation did not respond to our e-
mail invitations at all, so they would be very unlikely to respond to
a survey. Furthermore, the question is whether it would have revealed
additional barriers, because most barriers in our study were identified
by exploring them in-depth. Second, patients were involved in the
expert panel meeting, but not in the barrier identification. Results
might have been different if individual interviews were performed with
both professionals and patients. To reduce these possible differences,
all patients received an overview of the identified barriers 2 weeks
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prior to the expert panel meeting, in order to have enough time
to agree with the identified barriers and/or to add new barriers.
Third, bias could have occurred in the interpretation of the interview
transcripts. Therefore, all interview transcripts were independently
coded by two researchers, and discrepancies were discussed. Fourth,
most interviewed professionals worked at an academic hospital at
which FP awareness might be higher due to short communication lines
between oncology and fertility departments. However, this would also
signify an underestimation of the barriers.
The establishment and dissemination of the national clinical female
oncofertility care guideline is not sufficient to improve care. In order
to improve adherence to the guideline, implementation activities are
necessary. Our tailored improvement strategies form the basis for
a multifaceted oncofertility programme, which is an important and
essential implementation activity. In Canada and the United States of
America, dedicated cancer and fertility programmes were developed
and evaluated for their effect on patient satisfaction, information pro-
vision, and referral. These studies have shown improvements in patient
satisfaction and more referrals (Cohen et al. 2016; Kelvin et al. 2016;
Srikanthan et al. 2016). These outcomes are promising for the design
of a nationwide oncofertility programme in the Netherlands, since FP
care is reimbursed in our country and patients and professionals have
no financial reasons to refrain from referral for FP counselling.
Conclusion
In summary, this is the first study to identify barriers and tailor improve-
ment strategies associated with these barriers, with the aim of deliv-
ering optimal oncofertility care. Professionals particularly perceived
barriers in awareness, knowledge, attitude, and organization of female
oncofertility care. To overcome these barriers, patients and profes-
sionals selected seven tailored improvement strategies, including devel-
opment of patient information materials, education of professionals,
roles for specialized oncology nurses, and agreement in each hospital
on who is responsible for discussing infertility risks. This selection
forms the basis for a multifaceted oncofertility programme, which is
essential to increase adherence to the national clinical guideline on
female oncofertility care to provide a better quality of life for female
cancer survivors.
Supplementary data
Supplementary data are available at Human Reproduction online.
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